Common Contracts
2 similar Collaboration, Option and License Agreement contracts by Adverum Biotechnologies, Inc.
COLLABORATION, OPTION AND LICENSE AGREEMENTCollaboration, Option and License Agreement • April 5th, 2017 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS COLLABORATION, OPTION AND LICENSE AGREEMENT (the “Agreement”) is entered into as of August 8, 2016 (“Effective Date”), by and between ADVERUM BIOTECHNOLOGIES, INC., a Delaware corporation having an address at 1035 O’Brien Drive, Menlo Park, CA 94025 (“Adverum”), and EDITAS MEDICINE, INC., a Delaware corporation having an address at 300 Third Street, Cambridge, MA 02142 (“Editas”). Adverum and Editas may be referred to herein individually as a “Party” and collectively as the “Parties.”
COLLABORATION, OPTION AND LICENSE AGREEMENTCollaboration, Option and License Agreement • November 8th, 2016 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • Delaware
This Collaboration, Option and License Agreement (the “Agreement”) is entered into as of August 8, 2016 (“Effective Date”), by and between Adverum Biotechnologies, Inc., a Delaware corporation having an address at 1035 O’Brien Drive, Menlo Park, CA 94025 (“Adverum”), and Editas Medicine, Inc., a Delaware corporation having an address at 300 Third Street, Cambridge, MA 02142 (“Editas”). Adverum and Editas may be referred to herein individually as a “Party” and collectively as the “Parties.”
